Filter
1626
Text search:
data
profiles
Featured
Recommendations
160
New Publications
415
Language
Document type
No document type
804
Studies & Reports
321
Guidelines
270
Strategic & Response Plan
82
Manuals
80
Fact sheets
24
Situation Updates
18
Resource Platforms
11
Training Material
10
Infographics
3
Brochures
2
Dashboards/Maps
1
Countries / Regions
Global
91
India
48
Western and Central Europe
38
Kenya
34
South Africa
30
Latin America and the Carribbean
29
Ethiopia
28
Africa
28
Uganda
27
Myanmar / Burma
27
Sierra Leone
26
Nigeria
24
Nepal
24
Bangladesh
22
Namibia
22
Malawi
21
Ukraine
20
Rwanda
17
Philippines
16
Zambia
16
Ghana
15
Liberia
14
Congo, Democratic Republic of
14
Indonesia
14
Tanzania
13
Cambodia
13
Eastern Europe
13
Zimbabwe
12
Haiti
12
Lesotho
12
Brazil
11
Syria
10
Botswana
10
Asia
10
Mozambique
9
Eswatini/ Swaziland
9
South–East Asia Region
9
Guinea
8
Burkina Faso
8
Senegal
8
Eastern Europe and Central Asia
8
Cameroon
7
Pakistan
7
East and Southern Africa
7
South Sudan
6
Sudan
6
West and Central Africa
6
Paraguay
6
Venezuela
6
Afghanistan
5
Yemen
5
Tajikistan
5
Russia
5
Somalia
4
Germany
4
Benin
4
Burundi
4
Madagascar
4
Middle East and North Africa
4
Moldova
4
Côte d’Ivoire / Ivory Coast
3
Iraq
3
Lebanon
3
Turkey
3
Thailand
3
Papua New Guinea
3
Central African Republic
3
Libya
3
Angola
3
Poland
3
Georgia
3
Mali
2
Guinea-Bissau
2
Togo
2
Jordan
2
Chad
2
Gambia
2
Argentina
2
North Macedonia
2
Colombia
2
Ecuador
2
Albania
2
Armenia
2
Laos
2
Estonia
2
Romania
2
Maldives
2
Morocco
1
Saudi Arabia
1
Niger
1
Egypt
1
Singapore
1
Peru
1
Switzerland
1
Hungary
1
Honduras
1
El Salvador
1
Greece
1
Guatemala
1
Nicaragua
1
Chile
1
Western Pacific Region
1
Palestine
1
Italy
1
Djibouti
1
Timor Leste/ East Timor
1
Bulgaria
1
Iran
1
Kazakhstan
1
Vietnam
1
North America
1
Turkmenistan
1
Belgium
1
Tunisia
1
Belarus
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
564
Clinical Guidelines
167
Women & Child Health
113
Public Health
102
Key Resources
92
Pharmacy & Technologies
23
Capacity Building
14
Toolboxes
COVID-19
124
HIV
117
Mental Health
101
TB
98
NTDs
62
Planetary Health
59
AMR
57
NCDs
49
Refugee
42
Caregiver
41
Disability
37
Global Health Education
37
Pharmacy
35
Conflict
33
Rapid Response
28
Malaria
23
Ebola & Marburg
21
Natural Hazards
20
2.0 Rapid Response
16
Health Financing Toolbox
12
Polio
9
Zika
8
Cholera
6
Specific Hazards
6
Social Ethics
2
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir
...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto
...
The issue of Antimicrobial resistance has become one of the most substantial health issues, prompting the World Health Assembly (WHA) to urge Member States to finalise tailor made national action plans by May 2017, aligning them with objectives of the Global Action Plan (GAP). These cover awareness,
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i
...
Excessive consumption of salt (more than 5 g per day) raises blood pressure, a major risk factor for cardiovascular diseases such as heart disease and stroke, and is the leading cause of death in the WHO European Region. Many countries in the Region have initiated national salt reduction strategies,
...
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte
...
No Public Health without Refugee and Migrant health.
This report, the first of its kind, creates an evidence base with the aim of catalysing progress towards developing and promoting migrant-sensitive health systems in the 53 Member States of the WHO European Region and beyond. This report seeks to
...
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill
...
Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region
Since 2019, we have been implementing Phase 2 of the regional Transformation Agenda, which informs and aligns with the global WHO Transformation, to ensure WHO is accountable, driven by re- sults and provid
...
The World Health Organization (WHO) is releasing the second edition of its Global Accelerated Action for the Health of Adolescents (AA-HA!) guidance. The document aims to equip governments to respond to the health and well-being challenges, opportunities and needs of adolescents.
The guidance pro
...
The pandemic presents tough choices for governments, local communities, health and school systems, as well as families and businesses: How to re-open safely? How to safeguard people’s lives and protect their livelihoods? Where to allocate scarce resources? How to protect those unable to protect th
...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID
...
Every day in 2020, approximately 800 women died from preventable causes related to pregnancy and childbirth - meaning that a woman dies around every two minutes.
Sustainable Development Goal (SDG) target 3.1 is to reduce maternal mortality to less than 70 maternal deaths per 100 000 live births by
...
Vitamin A supplementation (VAS) programs targeted at children aged 6–59 months are implemented in many countries. By improving immune function, vitamin A (VA) reduces mortality associated with measles, diarrhea, and other illnesses. There is currently a debate regarding the relevance of VAS, but a
...
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor f
...
High levels of storage iron may increase malaria susceptibility. This risk has not been investigated in semi-immune adolescents. We investigated whether baseline iron status of nonpregnant adolescent girls living in a high malaria transmission area in Burkina Faso affected malaria risk during the fo
...
This is the 19th annual Landmine Monitor report. It is the sister publication to the Cluster Munition Monitor report, first published in November 2010.
Landmine Monitor 2016 provides a global overview of the landmine situation. Chapters on developments in specific countries and other areas are ava
...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
The World Health Organization and the Global Fund to Fight AIDS, Tuberculosis and Malaria are part of a group of agencies working together to accelerate progress towards the health-related SDGs through the Global Action Plan for Healthy Lives and Well-being for All. Understanding patterns of inequal
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized
...
